RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Axim Biotechnologies Stock

Axim Biotechnologies Equity 2025

Axim Biotechnologies Equity

-7.66 M USD

Ticker

AXIM

ISIN

US05463V1008

WKN

A2DF26

In 2025, Axim Biotechnologies's equity was -7.66 M USD, a 58.52% increase from the -4.83 M USD equity in the previous year.

Axim Biotechnologies Aktienanalyse

What does Axim Biotechnologies do?

Axim Biotechnologies Inc is an innovative biotechnology company focusing on the research, development, and marketing of pharmaceutical products, medical devices, and diagnostic tests based on cannabis. The company is headquartered in New York City and has become one of the leading companies in the industry since its founding in 2014. Axim Biotechnologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Axim Biotechnologies's Equity

Axim Biotechnologies's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Axim Biotechnologies's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Axim Biotechnologies's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Axim Biotechnologies's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Axim Biotechnologies’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Axim Biotechnologies stock

What is the equity of Axim Biotechnologies this year?

Axim Biotechnologies has equity of -7.66 M USD this year.

What was the equity of Axim Biotechnologies compared to the previous year?

The equity of Axim Biotechnologies has increased/decreased by 58.52% increased compared to the previous year.

What impact does a high equity have on investors of Axim Biotechnologies?

A high equity is advantageous for investors of Axim Biotechnologies as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Axim Biotechnologies?

A low equity can be a risk for investors of Axim Biotechnologies, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Axim Biotechnologies affect the company?

An increase in equity of Axim Biotechnologies can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Axim Biotechnologies affect the company?

A reduction in equity of Axim Biotechnologies can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Axim Biotechnologies?

Some factors that can affect the equity of Axim Biotechnologies include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Axim Biotechnologies so important for investors?

The equity of Axim Biotechnologies is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Axim Biotechnologies take to change the equity?

To change equity, Axim Biotechnologies can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Axim Biotechnologies pay?

Over the past 12 months, Axim Biotechnologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Axim Biotechnologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Axim Biotechnologies?

The current dividend yield of Axim Biotechnologies is .

When does Axim Biotechnologies pay dividends?

Axim Biotechnologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Axim Biotechnologies?

Axim Biotechnologies paid dividends every year for the past 0 years.

What is the dividend of Axim Biotechnologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Axim Biotechnologies located?

Axim Biotechnologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Axim Biotechnologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Axim Biotechnologies from 1/2/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/2/2025.

When did Axim Biotechnologies pay the last dividend?

The last dividend was paid out on 1/2/2025.

What was the dividend of Axim Biotechnologies in the year 2024?

In the year 2024, Axim Biotechnologies distributed 0 USD as dividends.

In which currency does Axim Biotechnologies pay out the dividend?

The dividends of Axim Biotechnologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Axim Biotechnologies

Our stock analysis for Axim Biotechnologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Axim Biotechnologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.